Literature DB >> 18158210

The Chinese health care regulatory institutions in an era of transition.

Jing Fang1.   

Abstract

The purpose of this paper is to contribute to a better understanding of Chinese health care regulation in an era of transition. It describes the major health care regulatory institutions operating currently in China and analyzes the underlying factors. The paper argues that in the transition from a planned to a market economy, the Chinese government has been employing a hybrid approach where both old and new institutions have a role in the management of emerging markets, including the health care market. This approach is consistent with the incremental reform strategy adopted by the Party-state. Although a health care regulatory framework has gradually taken shape, the framework is incomplete, with a particular lack of emphasis on professional self-regulation. In addition, its effectiveness is limited despite the existence of many regulatory institutions. In poor rural areas, the effectiveness of the regulatory framework is further undermined or distorted by the extremely difficult financial position that local governments find themselves in. The interpretations of the principle of 'rule of law' by policy makers and officials at different levels and the widespread informal network of relations between known individuals (Guanxi) play an important role in the operation of the regulatory framework. The findings of this paper reveal the complex nature of regulating health care in transitional China.

Mesh:

Year:  2007        PMID: 18158210     DOI: 10.1016/j.socscimed.2007.11.016

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  4 in total

1.  Multilevel and spatial analysis of syphilis in Shenzhen, China, to inform spatially targeted control measures.

Authors:  Xiaobing Wu; Joseph D Tucker; Fuchang Hong; Jane Messina; Lina Lan; Yufeng Hu; Tiejian Feng; Michael E Emch; Xiaoli Liu; Chunlai Zhang; Lizhang Wen
Journal:  Sex Transm Infect       Date:  2012-02-29       Impact factor: 3.519

2.  Evaluation of a pilot cooperative medical scheme in rural China: impact on gender patterns of health care utilization and prescription practices.

Authors:  Qicheng Jiang; Zhen Jiang; Ming Zhao; Jie Tao; Chunsun Ling; Nicola Cherry
Journal:  BMC Public Health       Date:  2011-01-24       Impact factor: 3.295

3.  Aspects of the Health Inspection Authority in the People's Republic of China.

Authors:  Sha Ma; Gang Chen; B-K Tan
Journal:  BMC Public Health       Date:  2015-05-20       Impact factor: 3.295

4.  Addressing antimicrobial resistance in China: policy implementation in a complex context.

Authors:  Li Wang; Xiulan Zhang; Xiaoyun Liang; Gerald Bloom
Journal:  Global Health       Date:  2016-06-06       Impact factor: 4.185

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.